Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Clin Chim Acta 411:17281734 Wen T, Zhu W, Xue C et al (2014) Novel electrochemical sensing platform based on magnetic field-induced self-assembly of Fe 3 O 4 @polyaniline nanoparticles for clinical detection of creatinine
Future studies will reveal the applicability of our model, for example, to activate enzymatically inactive glutaredoxins, to alter the sensitivity and responsiveness of glutaredoxin-coupled fluorescent redox sensors, to further address the catalytic mechanism with GSSCys, HEDS and physiological substrates, or to design specific transition-state inhibitors
A: The dosage of this medicine is 50 mg, and the dosage guidelines should be followed as per the doctors suggestion
Animal Model Evidence The systemic evidence base is entirely preclinical: Pulmonary fibrosis (mouse model): Intraperitoneal GHK-Cu at 0.2-20 micrograms/g/day protected against bleomycin-induced lung fibrosis by inhibiting TGF-beta1/Smad signaling and reducing oxidative stress (PMID 31809714)
US$ 28.50
US$ 29.35
US$ 26.38
US$ 24.46
US$ 24.72
